Aprogen Pharmaceuticals Inc (003060) — Cash Flow Reinvestment Rate
Aprogen Pharmaceuticals Inc (003060) has a Cash Flow Reinvestment Rate of 1.29x as of December 2022, reinvesting ₩870.30 Million (capex ₩591.03 Million plus investments ₩-279.27 Million) from operating cash flow of ₩676.93 Million. Check Aprogen Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aprogen Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Aprogen Pharmaceuticals Inc across 7 annual periods. Explore Aprogen Pharmaceuticals Inc (003060) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year capital reinvestment analysis for Aprogen Pharmaceuticals Inc. For live market cap and broader valuation context, see how much is Aprogen Pharmaceuticals Inc worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.12x | ₩54.55 Billion | ₩25.73 Billion | ₩1.55 Billion | ▼ -76.0% |
| 2020 | 8.84x | ₩71.48 Billion | ₩8.09 Billion | ₩976.29 Million | ▼ -85.4% |
| 2019 | 60.44x | ₩43.14 Billion | ₩713.73 Million | ₩2.13 Billion | ▲ +92.7% |
| 2018 | 31.37x | ₩41.77 Billion | ₩1.33 Billion | ₩1.01 Billion | ▼ -63.2% |
| 2016 | 85.22x | ₩38.35 Billion | ₩449.98 Million | ₩2.82 Billion | ▲ +733.9% |
| 2015 | 10.22x | ₩18.88 Billion | ₩1.85 Billion | ₩5.37 Billion | ▼ -79.4% |
| 2010 | 49.52x | ₩12.28 Billion | ₩247.92 Million | ₩12.28 Billion | — |